"Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCL

Clinical trial NCT06559553 · RECRUITING

Trial details

NCT number: NCT06559553
Sponsor: Mingzhi Zhang
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

NKTCL Selinexor

Start date: 2024-09-01
Primary completion: 2026-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.